1. Home
  2. OPK vs PLSE Comparison

OPK vs PLSE Comparison

Compare OPK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.37

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$14.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPK
PLSE
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
OPK
PLSE
Price
$1.37
$14.02
Analyst Decision
Buy
Buy
Analyst Count
5
1
Target Price
$2.28
$22.00
AVG Volume (30 Days)
2.8M
183.4K
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$642,067,000.00
$86,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,002.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$12.56
52 Week High
$2.04
$25.00

Technical Indicators

Market Signals
Indicator
OPK
PLSE
Relative Strength Index (RSI) 50.91 48.44
Support Level $1.35 $13.12
Resistance Level $1.42 $14.75
Average True Range (ATR) 0.05 0.64
MACD 0.01 0.24
Stochastic Oscillator 61.11 63.33

Price Performance

Historical Comparison
OPK
PLSE

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: